State of Wyoming »

Lineage Cell Therapeutics In shares owned by State of Wyoming

Quarter-by-quarter ownership of Lineage Cell Therapeutics In (LCTX) shares owned by State of Wyoming from 13F filings

Historical chart of State of Wyoming investment in Lineage Cell Therapeutics In

Tip: Access up to 7 years of quarterly data

All positions including Lineage Cell Therapeutics In held by State of Wyoming consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lineage Cell Therapeutics In by State of Wyoming

Quarter filed Position value Share count Share price at filing
2026-06-30 $58k 44k 1.31

More positions owned by State of Wyoming

State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Ishares Tr Msci Eafe Etf (EFA)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Ishares Msci Emrg Chn (EMXC)
Alphabet Cap Stk Cl A (GOOGL)
Ishares Msci Taiwan Etf (EWT)
Alphabet Cap Stk Cl C (GOOG)
Marvell Technology (MRVL)
Micron Technology (MU)
Interactive Brokers Group In Com Cl A (IBKR)
Meta Platforms Cl A (META)
Incyte Corporation (INCY)
Tower Semiconductor Shs New (TSEM)

View all positions for State of Wyoming

Top funds holding Lineage Cell Therapeutics In

Broadwood Capital
BlackRock
Vanguard Capital Management
Defender Capital
Geode Capital Management
Raffles Associates
Fifth Third Bancorp
Millennium Management
Morgan Stanley
Vanguard Fiduciary Trust
Northern Trust
Renaissance Technologies
Marshall Wace
Vanguard Portfolio Management
State Street Corporation

View all funds holding Lineage Cell Therapeutics In